Benzoquinone inhibits the voltage-dependent induction of the mitochondrial permeability transition caused by redox-cycling naphthoquinones

Toxicology and Applied Pharmacology

Volumn 143, Issue 2, 1997, Pages 338-347

  Palmeira, Carlos M ^a   Wallace, Kendall B ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 NAPHTHOQUINONE; 1,4 NAPHTHOQUINONE DERIVATIVE; 2,3 DIMETHOXY 1,4 NAPHTHOQUINONE; BENZOQUINONE; CYCLOSPORIN A; MENADIONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; LIVER MITOCHONDRION; MEMBRANE DEPOLARIZATION; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; NONHUMAN; OXIDATION REDUCTION REACTION; RAT;

EID: 0030932708     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.8099     Document Type: Article

References (41)

1. Bernardi P. Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. J. Biol. Chem. 267:1992;8834-8839.
2. Bernardi P., Broekemeier K. M., Pfeiffer D. R. Recent progress on regulation of the mitochondrial permeability transition pore, a cyclosporin-sensitive pore in the inner mitochondrial membrane. J. Bioenerg. Biomembr. 26:1994;509-517.
3. Bernardi P., Vassanelli S., Veronese P., Colonna R., Szabo I., Zoratti M. Modulation of the mitochondrial permeability transition pore: Effect of protons and divalent cations. J. Biol. Chem. 267:1992;2934-2939.
4. 2+. J. Biol. Chem. 268:1993;1005-1010.
5. Birch-Machin M., Jackson S., Kler R. S., Turnbull D. M. Study of skeletal muscle mitochondrial dysfunction. Methods of Toxicology: Mitochondrial Dysfunction. 1993;Academic Press, San Diego. p. 51-69.
6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
7. 2+. FEBS Lett. 304:1992;192-194.
8. Broekemeier K. M., Dempsey M. E., Pfeiffer D. R. Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264:1989;7826-7830.
9. Costantini P., Chernyak B. V., Petronilli V., Bernardi P. Selective inhibition of the mitochondrial permeability transition pore at the oxidation-reduction sensitive dithiol by monobromobimane. FEBS Lett. 362:1995;239-242.
10. 2+. J. Biol. Chem. 265:1990;1955-1960.
11. Floreani M., Carpenedo F. Modifications of cardiac contractility by redox cycling, alkylating and mixed redox cycling/alkylating quinones. J. Pharmacol. Exp. Ther. 256:1991;243-248.
12. Gant T. W., Ramakrishna Rao D. N., Mason R. P., Cohen G. M. Redox cycling and sulphydryl arylation: Their relative importance in the mechanism of quinone cytotoxicity to isolated hepatocytes. Chem.-Biol. Interact. 65:1988;157-173.
13. Gunter T. E., Gunter K. K., Sheu S.-S., Gavin C. E. Mitochondrial calcium transport: physiological and pathological relevance. Am. J. Physiol. 267:1994;C313-C339.
14. Gunter T. E., Pfeiffer D. R. Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258:1990;C755-C786.
15. Harman A. W., Maxwell M. J. An evaluation of the role of calcium in cell injury. Annu. Rev. Pharmacol. Toxicol. 35:1995;129-144.
16. Henry T. R., Solem L. E., Wallace K. B. Channel-specific induction of the cyclosporine A-sensitive mitochondrial permeability transition by menadione. J. Toxicol. Environ. Health. 45:1995;489-504.
17. Henry T. R., Wallace K. B. Differential mechanisms of induction of the mitochondrial permeability transition by quinones of varying chemical reactivities. Toxicol. Appl. Pharmacol. 134:1995;195-203.
18. Henry T. R., Wallace K. B. Differential mechanisms of cell killing by redox cycling and arylating quinones. Arch. Toxicol. 70:1996;482-489.
19. Imberti R., Nieminen A.-L., Herman B., Lemasters J. J. Mitochondrial and glycolytic dysfunction in lethal injury to hepatocytes by t-butylhydroperoxide: Protection by fructose, cyclosporin A and trifluoperazine. J. Pharmacol. Exp. Ther. 265:1993;392-400.
20. 2+. Biochem. Pharmacol. 44:1992;1995-2003.
21. Kosower N. S., Kosower E. The glutathione status of cells. Int. Rev. Cytol. 58:1978;109-160.
22. Meredith M. J., Reed D. J. Status of the mitochondrial pool of glutathione in isolated hepatocytes. J. Biol. Chem. 257:1982;3747-3753.
23. Meredith M. J., Reed D. J. Depletion in vitro of mitochondrial glutathione in rat hepatocytes and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol. 32:1983;1383-1388.
24. Palmeira C. M., Moreno A. J., Madeira V. M. C. Interactions of herbicides 2,4-D and dinoseb with liver mitochondrial bioenergetics. Toxicol. Appl. Pharmacol. 127:1994;50-57.
25. Palmeira C. M., Moreno A. J. M., Madeira V. M. C., Wallace K. B. Continuous monitoring of mitochondrial membrane potential in hepatocyte cell suspensions. J. Pharmacol. Toxicol. Methods. 35:1996;35-43.
26. Pastorino J. G., Snyder J. W., Serroni A., Hoek J. B., Farber J. L. Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem. 268:1993;13791-13798.
27. 2+. J. Biol. Chem. 268:1993a;1011-1016.
28. Petronilli V., Cola C., Massari S., Colonna R., Bernardi P. Physiological effectors modify voltage sensing by the cyclosporin A-sensitive permeability transition pore of mitochondria. J. Biol. Chem. 268:1993b;21939-21945.
29. Petronilli V., Costantini P., Scorrano L., Colonna R., Passamonti S., Bernardi P. The voltage sensor of the mitochondrial permeability transition pore is tuned by the oxidation-reduction state of vicinal thiols. J. Biol. Chem. 269:1994;16638-16642.
30. Powis G., Appel P. L. Relationship of the single electron reduction potential of quinones to their reduction by flavoproteins. Biochem. Pharmacol. 29:1980;2567-2572.
31. Reed D. J. Glutathione: Toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30:1990;603-631.
32. 2+. Chem.-Biol. Interact. 77:1991;1-23.
33. 2+. Eur. J. Biochem. 162:1987;239-249.
34. Rossi D., Moore G. A., Orrenius S., O'Brien P. J. Quinone toxicity in hepatocytes without oxidative stress. Arch. Biochem. Biophys. 251:1986;25-35.
35. Saxena K., Henry T. R., Solem L. E., Wallace K. B. Enhanced induction of the mitochondrial permeability transition following acute menadione administration. Arch. Biochem. Biophys. 317:1995;79-84.
36. Snyder J. W., Pastorino J. G., Attie A. M., Farber J. L. Protection by cyclosporin A of cultured hepatocytes from the toxic consequences of the loss of mitochondrial energization produced by 1-methyl-4-phenylpyridinium. Clin. Pharmacol. 44:1992;833-835.
37. Szabo I., De Pinto V., Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. FEBS Lett. 330:1993;206-210.
38. Szabo I., Zoratti M. The mitochondrial megachannel is the permeability transition pore. J. Bioenerg. Biomembr. 24:1992;111-117.
39. Szabo I., Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. FEBS Lett. 330:1993;201-205.
40. ++++. J. Pharmacol. Exp. Ther. 245:1988;501-507.
41. Zoratti M., Szabo I. The mitochondrial permeability transition. Biochim. Biophys. Acta. 1241:1995;139-176.